Benign prostatic hyperplasia (BPH) is the most prevalent disease in the ageing male and the incidence of symptomatic disease is likely to increase in the millenium with increased life expectancy. BPH can have a severe impact on quality of life, including sexual function, and yet many men do not seek medical attention for this and many other diseases. Surgery is no longer a mandatory treatment for BPH. Medical management can provide excellent symptom relief and improvement in urinary¯ow rates, as well as quality of life, and men need to be made aware of this in order to make informed treatment decisions. In the broader context, men should be encouraged to become more health conscious and develop a more positive attitude towards their health.
Prevalence of BPH
Benign prostatic hyperplasia (BPH) is the most prevalent disease among men beyond middle age. Autopsy studies show that histological BPH is present in 50% of men in their 60s, rising to 90% in men b 85 years of age. 1 The proportion of men with palpable prostatic enlargement is rather less, with a prevalence of 21% in men aged 50 ± 60 y and 53% in men in their 80s. More important is the proportion of men actually troubled by the lower urinary tract symptoms (LUTS) associated with BPH. Results show that, again, the incidence of these symptoms increases with age (Table 1 ). 2 ± 6 Worldwide, there is a pronounced shift towards an increasingly aged society, and as a result, more patients will be diagnosed with BPH and require treatment. By the year 2000, male life expectancy will exceed 80 y in many countries, and the majority of men can therefore be expected to have an 88% chance of developing histological BPH and a 50% chance of developing symptomatic BPH.
Effect of BPH on quality of life
Although BPH is a common disease which is rarely lifethreatening, it can result in signi®cant impairment in the patient's quality of life. A study by Garraway and associates 7 indicates that about half of the men with evidence of obstructive BPH (de®ned as a prostate on transrectal ultrasonography b 20 g, and symptoms of urinary dysfunction and/or a peak urine¯ow rate of`15 mL/s) reported interference with one or more activities of daily living, compared with 28% of men without the condition. 7 In addition to this impairment in quality of life, many patients reported worry and embarrassment about their urinary function. 8 A recent study shows that sexual dysfunction is increased in men with LUTS associated with BPH. Sexual expression was affected by 45% of men reporting such symptoms to a urology clinic in one of 12 countries and by 7% of community-dwelling men aged 40 y and over. 9 In this and other ways, BPH can impact not only on the man but also on his partner.
A number of speci®c questionnaires have been developed to assess the impact on quality of life of BPH and its treatment. One long-term study by Lukacs and coworkers 10 involving 7093 patients in general practice used a self-administered questionnaire, which measured responses on a visual analogue scale. Three main components of quality of life were identi®ed: BPH-speci®c interference with activities, general quality of life and sexuality.
Men's Health
Real differences exist between men and women in terms of health and disease. On average, men do not live as long as women and a survival gap of 5.6 y in favour of women existed in 1974; estimated life expectancies at birth were 73.6 y for men and 79.2 y for women. 11 A report from the US shows that mortality levels for each of the leading causes of death for the total population are higher for males than females ( Figure 1 ). 12 In terms of overall mortality in the US, women outnumber men by ®ve to four at age 65 ± 69 y, by ®ve to three at age 75 ± 79 y and by ®ve to three at age 85 ± 89 y. 13 Men also tend to be risk takers compared with women. They make unhealthy choices and are more likely to smoke, 14 to drink alcohol heavily, 15 to be involved in murder, motor vehicle accidents and other accidents, 16 to suffer traumatic brain injury, 17 to commit suicide 18 and to die from acquired immune de®ciency syndrome (AIDS).
Fewer men than women visit their doctor on a regular basis to obtain preventive health-care examinations. The reasons men give for this are denial, fear, embarrassment and a desire to avoid an experience outside their control. A Danish study recorded the reluctance among men aged 60 ± 79 y to consult a doctor about prostatic symptoms. 19 Why they do not seek medical help remains unclear, but some of the most likely reasons are shown in Table 2 .
It has been proposed that adult men suffer a mild form of alexithymia Ð the inability to identify and describe one's feelings in words. 20 The effect of this is to not report discomfort that may indicate illness. This may stem from male gender role socialisation, where boys are required to control their vulnerability and caring emotions and to remain emotionally stoic.
Every year, 10 000 men in England and Wales die of prostate cancer, which is four times the number of women who die of cervical cancer. Despite women living longer and men being more likely to commit suicide, take drugs, go to jail and die of cancer, the National Health Service in the UK spends eight times more money on women's health than on that of men.
What can be done?
BPH is an eminently treatable disease, with several safe and effective therapeutic options available. Surgery used to be the main therapeutic option for BPH and is still mandatory for a number of conditions including: urinary retention, recurrent urinary tract infection or gross haematuria, bladder stones, large bladder diverticula and renal failure. 21 However, surgery is not a necessity in all cases and patients may in fact be more suited to medical therapy; for example, those with less bothersome symptoms or those with bothersome symptoms who have not developed one of the serious complications indicated above. Indeed, the rate of transurethral resection of the prostate procedures has fallen worldwide in the past 10 years. 22 Medical therapy is now a legitimate and safe ®rst-line treatment option with positive bene®ts. The main options for the medical treatment of BPH are a 1 -blockers and 5a-reductase inhibitors. Currently available a 1 -blockers appear to have similar ef®cacy, producing symptom improvement rates of around 40% and improving maximum¯ow rate by 30 ± 35%. a 1 -Blockers are generally well tolerated, and side effects can be reversed upon treatment discontinuation. The other major medical option, 5a-reductase inhibitors, can produce improve- Table 2 Reasons why men with symptoms of prostatic disease do not present to their doctor 20 Perception that symptoms are a normal feature of ageing Fear of a diagnosis of cancer Fear of surgery and its potential side effects Reluctance to discuss symptoms with a female family practitioner Fear of ridicule and embarrassment of discussing symptoms Dislike of digital rectal examination and other tests Reluctance to leave the home for diagnosis and treatment ment in symptoms (20 ± 30%) and maximum¯ow rate (20%); 23, 24 the effects are greater in men with prostates greater than 40 mL. 25 a 1 -Blockers have a clear advantage in that they are faster acting, with effects frequently being observed within the ®rst two to three weeks of treatment 26 compared with at least three to six months with 5a-reductase inhibitors. 23, 24 As a result of these advantages, a 1 -blockers are recommended as a ®rst-line therapy for many BPH sufferers. Physicians should provide full information on treatment options to their patients, so that together an informed decision can be made. Regarding men's health in general, there is clearly scope for improving both the level of public education and the knowledge of health-care professionals in this area. Women in particular could be the focus of an educational drive on understanding the disease. In turn, they might encourage their partners to consult a doctor when the need arises. Ideally, the target should be men themselves and to make men responsible for their own health. Education on health matters needs to be started at an early age to get away from the old doctrines of how boys and girls should react differently to emotions in general and wellbeing in particular.
Men's health should focus on primary prevention. Determinants of health behaviour should be studied as 60% of chronic disease is the result of behaviour or lifestyle. Men need to be convinced that preventive health practices will extend their lives. If primary prevention fails, early detection is the next step. To achieve this, men need to change their attitude towards health checkups and request regular physical examinations to detect disease at an earlier stage. Currently, many men regard the maxim`if it isn't broken, don't ®x it' as applicable to their health. Instead, they need to be educated to take the view that`if you look after it, it is less likely to break'.
Conclusion
BPH and prostatic diseases should be looked at in the broader context of men's health. Education is needed to encourage men to adopt a healthy lifestyle and a more positive attitude towards their own health. They should also be motivated to take preventative action and act upon early signs of disease. As women have a champion of their health in the form of the obstetrician-gynaecologist, then so should men. This is the challenge for the urologist as we approach the dawn of the 21 st century.
